Crexont | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

41 results for “Crexont”

Trials

View all 26 →

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

220 participants · First posted Jan 9, 2025

BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease

22 participants · First posted Aug 24, 2025

Cremona Population-Based Gastric Tumors Registry

1,000 participants · First posted Aug 10, 2012

Organizations

Boehringer Ingelheim Fremont, Inc.

United States

News

View all 14 →

Amneal's CREXONT Shows Significant Sleep Quality Improvements in Parkinson's Disease Patients

FDA Approves Crexont for Parkinson's Disease Treatment

Amneal's CREXONT Shows Significant Clinical Benefits in Phase 4 Parkinson's Disease Study

Page 1 of 5